Chmel H - Search Results

1

Blastomycosis in patients with the acquired immunodeficiency syndrome.

Pappas PG, Pottage JC, Powderly WG, Fraser VJ, Stratton CW, McKenzie S, Tapper ML, Chmel H, Bonebrake FC, Blum R, et al. Pappas PG, et al. Among authors: chmel h. Ann Intern Med. 1992 May 15;116(10):847-53. doi: 10.7326/0003-4819-116-10-847. Ann Intern Med. 1992. PMID: 1567099

2

Pneumocystis carinii pneumonia. The steroid dilemma.

Chmel H. Chmel H. Arch Intern Med. 1990 Sep;150(9):1793-4. Arch Intern Med. 1990. PMID: 2393313 No abstract available.

3

Fatal acute hepatic necrosis due to fluconazole.

Chmel H. Chmel H. Am J Med. 1995 Aug;99(2):224-5. doi: 10.1016/s0002-9343(99)80148-x. Am J Med. 1995. PMID: 7625431 No abstract available.

4

Sepsis in the 1990s: The Management of Chaos.

Toney JF, Greene JN, Chmel H. Toney JF, et al. Among authors: chmel h. Cancer Control. 1994 Oct;1(5):539-544. Cancer Control. 1994. PMID: 10887007 No abstract available.

5

Stevens-Johnson syndrome presumably induced by ciprofloxacin.

Win A, Evers ML, Chmel H. Win A, et al. Among authors: chmel h. Int J Dermatol. 1994 Jul;33(7):512-4. doi: 10.1111/j.1365-4362.1994.tb02870.x. Int J Dermatol. 1994. PMID: 7928041 No abstract available.

6

Imipenem resistance in Enterobacter.

Thomson KS, Sanders CC, Chmel H. Thomson KS, et al. Among authors: chmel h. Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):610-3. doi: 10.1007/BF01973639. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8223659

7

Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.

Hazinski MF, Iberti TJ, MacIntyre NR, Parker MM, Tribett D, Prion S, Chmel H. Hazinski MF, et al. Among authors: chmel h. Am J Crit Care. 1993 May;2(3):224-35; quiz 236-7. Am J Crit Care. 1993. PMID: 8364674 Review.

8

Antiendotoxin monoclonal antibodies for gram-negative sepsis.

Chmel H, Emmanuel G. Chmel H, et al. Clin Infect Dis. 1992 Aug;15(2):371-2. doi: 10.1093/clinids/15.2.371. Clin Infect Dis. 1992. PMID: 1520771 No abstract available.

9

The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.

Gorelick KJ, Chmel H. Gorelick KJ, et al. Among authors: chmel h. Infect Dis Clin North Am. 1991 Dec;5(4):899-913. Infect Dis Clin North Am. 1991. PMID: 1783775 Review.

10

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.

Greenman RL, Schein RM, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G, Chmel H, Kohler RB, McCarthy M, Plouffe J, et al. Greenman RL, et al. Among authors: chmel h. JAMA. 1991 Aug 28;266(8):1097-102. JAMA. 1991. PMID: 1865542 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page